CCL22 and myeloid sarcoma: As a result, ten cytokines, sCD40L, MCP-1, MIP-1b, PDGF-AA, MDC, EGF, IL-8, TGF-a, PDGF-AB/BB, and VEGF, were found to be lower in MS patients.